About the Authors
- Mira C. Patel
-
Affiliations Sigmovir Biosystems Inc., Rockville, Maryland, United States of America, Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, United States of America
- Wei Wang
-
Affiliation Infectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America
- Lioubov M. Pletneva
-
Affiliation Sigmovir Biosystems Inc., Rockville, Maryland, United States of America
- Seesandra V. Rajagopala
-
Affiliation Infectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America
- Yi Tan
-
Affiliation Infectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America
- Tina V. Hartert
-
Affiliation Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
- Marina S. Boukhvalova
-
Affiliation Sigmovir Biosystems Inc., Rockville, Maryland, United States of America
- Stefanie N. Vogel
-
Affiliation Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, United States of America
- Suman R. Das
-
* E-mail: j.blanco@sigmovir.com (JCGB); suman.r.das@vanderbilt.edu (SRD)
Current address: Center for Translational Immunology and Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
Affiliation Infectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America
- Jorge C. G. Blanco
-
* E-mail: j.blanco@sigmovir.com (JCGB); suman.r.das@vanderbilt.edu (SRD)
Affiliation Sigmovir Biosystems Inc., Rockville, Maryland, United States of America
Competing Interests
JCGB and MSB are co-founders and serves as President and Chief Scientific Officer for Sigmovir Biosystems, Inc., respectively. All other authors declare no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: MCP SRD MSB JCGB. Data curation: MCP SRD JCGB. Formal analysis: MCP SRD JCGB. Funding acquisition: SRD SNV MSB JCGB. Investigation: MCP SRD JCGB. Methodology: MCP WW LMP SVR. Project administration: JCGB. Resources: TVH SRD JCGB. Software: YT. Supervision: SRD JCGB. Validation: MCP SRD JCGB. Visualization: MCP JCGB. Writing – original draft: MCP. Writing – review & editing: MCP MSB SNV SRD JCGB.